Government launches Biodiscovery Platform to grow New Zealand’s bioeconomy

The Biodiscovery Platform represents a new frontier in how New Zealand supports science-led commercialisation.

While the science system has long backed innovation in agriculture and technology, biodiscovery has not been targeted strategically, even though it offers huge economic potential.

New Zealand is home to more than 80,000 indigenous species, many of which contain bioactive compounds with potential applications in pharmaceuticals, cosmetics, functional foods, and natural health products.

With global demand for these products projected to exceed USD$300 billion by 2027, the platform positions New Zealand to lead in a high-growth sector.

Up to $42.8 million over seven and a half years will be invested in the platform, which will be hosted by the New Zealand Institute for Bioeconomy Science (BSI).

BSI was selected for its deep expertise, strong track record in commercialising science, and enduring partnerships with Māori. Its ability to deliver multi-year, multi-agency programmes and its alignment with the Māori economy make it an ideal host.